UBS Group
LH icon

UBS Group’s Labcorp LH Stock Holding History

UBS Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$57.4K – 10899
2025
Q3 		$57.4K Hold
200
– – ﹤0.01% 7469
2025
Q2 		$52.5K Hold
200
– – ﹤0.01% 7727
2025
Q1 		$46.5K Buy
+200
New +$48.5K ﹤0.01% 7647
2023
Q1 		– Sell
-116
Closed -$23.5K – 10014
2022
Q4 		$23.5K Sell
116
-117
-50% -$22.9K ﹤0.01% 7482
2022
Q3 		$41K Buy
+233
New +$47.7K ﹤0.01% 6544
2022
Q1 		– Sell
-233
Closed -$63K – 10612
2021
Q4 		$63K Buy
+233
New +$57.7K ﹤0.01% 6707
2021
Q1 		– Sell
-116
Closed -$20K – 9264
2020
Q4 		$20K Sell
116
-8,265
-99% -$1.43M ﹤0.01% 6944
2020
Q3 		$1.36M Buy
8,381
+8,265
+7,125% +$1.31M ﹤0.01% 3414
2020
Q2 		$17K Sell
116
-8,381
-99% -$1.16M ﹤0.01% 6659
2020
Q1 		$923K Buy
+8,497
New +$1.22M ﹤0.01% 3418

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group's LH Position: Q1 2026 in Review

UBS Group increased its Labcorp (LH) stake by 14% in Q1 2026, buying an estimated $18.7M and bringing the position to 564,529 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #768.

UBS Group first reported a position in LH in Q4 2014 and has held it in 46 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • UBS Group held 564,529 shares of Labcorp worth $151M as of Q1 2026.
  • UBS Group bought 68,994 Labcorp shares in Q1 2026, an estimated $18.7M.
  • Labcorp made up 0.02% of UBS Group's portfolio in Q1 2026, its #768 holding.
  • UBS Group first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.